No abstract available
Keywords:
BCMA; Myeloma; bispecific antibodies; elranatamab; teclistamab.
MeSH terms
-
Antibodies, Bispecific* / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
B-Cell Maturation Antigen* / antagonists & inhibitors
-
B-Cell Maturation Antigen* / metabolism
-
Drug Resistance, Neoplasm
-
Humans
-
Multiple Myeloma* / drug therapy
-
Multiple Myeloma* / therapy
-
Recurrence
Substances
-
Antibodies, Bispecific
-
B-Cell Maturation Antigen
-
Antibodies, Monoclonal, Humanized